# A Randomized Controlled Trial of Doxazosin for Nightmares, Sleep Disturbance, and Non-Nightmare Clinical Symptoms in PTSD

> **NCT03339258** · PHASE2 · UNKNOWN · sponsor: **San Francisco Veterans Affairs Medical Center** · enrollment: 80 (estimated)

## Conditions studied

- Stress Disorders, Post-Traumatic

## Interventions

- **DRUG:** Doxazosin Mesylate, Extended Release
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03339258
- **Lead sponsor:** San Francisco Veterans Affairs Medical Center
- **Sponsor class:** FED
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-04-15
- **Primary completion:** 2024-06
- **Final completion:** 2024-06
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2024-05-01

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03339258

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03339258, "A Randomized Controlled Trial of Doxazosin for Nightmares, Sleep Disturbance, and Non-Nightmare Clinical Symptoms in PTSD". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03339258. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*